Silence Therapeutics (SLN)
(Delayed Data from NSDQ)
$21.74 USD
+0.32 (1.49%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $21.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/21/24 |
---|---|
Current Quarter | -0.32 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 78.26% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.52 |
Next Year | -1.36 |
EPS (TTM) | -1.16 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.28M | 5.58M | 35.92M | 47.78M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 18.63M | 7.61M | 39.93M | 109.08M |
Low Estimate | 6.35M | 2.79M | 33.03M | 8.81M |
Year ago Sales | 11.40M | 3.54M | 31.36M | 35.92M |
Year over Year Growth Est. | -1.03% | 57.71% | 14.53% | 33.03% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.32 | -0.41 | -1.52 | -1.36 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.34 | -0.36 | -2.09 | -2.25 |
High Estimate | -0.23 | -0.36 | -1.10 | -0.15 |
Low Estimate | -0.38 | -0.46 | -2.09 | -2.25 |
Year ago EPS | -0.36 | -0.28 | -1.45 | -1.52 |
Year over Year Growth Est. | 11.11% | -46.43% | -4.83% | 10.74% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.32 | -0.41 | -1.52 | -1.36 |
7 Days Ago | -0.32 | -0.41 | -1.52 | -1.36 |
30 Days Ago | -0.32 | -0.41 | -1.52 | -1.36 |
60 Days Ago | -0.32 | -0.41 | -1.52 | -1.36 |
90 Days Ago | -0.17 | -0.37 | -1.38 | -1.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.32 | -0.41 | -1.52 | -1.36 |
Zacks Consensus Estimate | -0.32 | -0.41 | -1.52 | -1.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -0.47 | -0.28 | -0.36 | NA |
Estimate | -0.23 | -0.25 | -0.56 | -0.59 | NA |
Difference | 0.18 | -0.22 | 0.28 | 0.23 | 0.12 |
Surprise | 78.26% | -88.00% | 50.00% | 38.98% | 19.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more